![Michael Rogers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Rogers
Direktor/Vorstandsmitglied bei
AKEBIA THERAPEUTICS, INC.
Vermögen: 201 378 $ am 31.05.2026
Profil
Michael W.
Rogers is an Independent Director at Akebia Therapeutics, Inc. since 2018.
Former roles include Chairman at Keryx Biopharmaceuticals, Inc. from 2017 to 2018; Independent Director at Fortress Biotech, Inc. from 2012 to 2013; Independent Director at Aravive, Inc. from 2020 to 2024; Independent Non-Executive Director at EyePoint, Inc. from 2005 to 2019; Chief Financial Officer, Treasurer & Executive Vice President at Indevus Pharmaceuticals, Inc. from 1999 to 2009; Vice President-Investment Banking at Lehman Brothers, Inc. from 1994 to 1995; Chief Financial Officer, Treasurer & Vice President at AutoImmune, Inc. from 1995 to 1997; Chief Financial Officer & Executive Vice President at AHT Corp.
in 1998; Chief Financial Officer at Acorda Therapeutics, Inc. from 2013 to 2016; Chief Financial Officer, Treasurer & Executive Vice President at BG Medicine, Inc. from 2011 to 2012; Vice President-Investment Banking at PaineWebber, Inc. in 1994; Chief Financial & Business Officer at Aerpio Pharmaceuticals, Inc. in 2019; and Chief Financial Officer at Apnimed, Inc. from 2020 to 2024.
Education includes undergraduate studies at Union College (New York) and an MBA from the University of Virginia Darden School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 197.429 ( 0,07 % ) | 201 378 $ | 31.05.2026 |
Aktive Positionen von Michael Rogers
| Unternehmen | Position | Beginn |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 12.12.2018 |
Ehemalige bekannte Positionen von Michael Rogers
| Unternehmen | Position | Ende |
|---|---|---|
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Finanzdirektor/CFO | 01.04.2024 |
| ARAVIVE, INC. | Direktor/Vorstandsmitglied | 17.01.2024 |
| AERPIO PHARMACEUTICALS | Finanzdirektor/CFO | 15.10.2019 |
| EYEPOINT, INC. | Direktor/Vorstandsmitglied | 01.06.2019 |
| KERYX BIOPHARMACEUTICALS | Vorsitzender | 12.12.2018 |
Ausbildung von Michael Rogers
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical compounds for urology, gynecology, and infectious diseases | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
AutoImmune, Inc.
 AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Health Technology |
AHT Corp.
 AHT Corp. Services to the Health IndustryHealth Services Provides clinical e-Commerce services | Health Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
BG Medicine, Inc.
 BG Medicine, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Union College (New York)
 Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Apnimed, Inc.
Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
